It was just announced that the FDA has granted a 510(k) market clearance to Lexington International, makers of the HairMax LaserComb, for the treatment of Androgenetic Alopecia (male pattern hair loss). After years of clinical trials and delays, as well as much skepticism amongst the medical community, is it encouraging to finally see Lexington achieve this milestone. Having used Low Level Laser Therapy in my practice since 1999, I've seen the results of laser therapy for hair loss patients first-hand for some time. Many of my patients have benefited from in-office treatments, as well as from hand-held devices. Through the years, there has been an extreme amount of skepticism amongst the medical community as to the benefits of light-therapy in the treatment of hair loss--as well as significant amount of ridicule (both public and private) directed towards physicians who supported its use years ago.
It is interesting to note that in my practice, I have actually seen better results in our female patients who have used laser therapy. But one thing is for sure, no matter what non-invasive treatment you use, the earlier you start treatment the better. Currently, in my practice, we encourage patients to use a multi-therapy approach, which includes the FDA-approved therapies (Propecia, Minoxidil, and laser therapy) as well as surgical therapies (hair transplantation) to help patients reach their goals.
At Bauman Medical, we offer treatments with the following Laser Therapy devices:
- Sunetics "E-type" in-office hood
- Erchonia "THL-1" (handheld)
- Lexington HairMax "LaserComb" (handheld)
- Sunetics LaserBrush (handheld)
For more information on hand-held low level lasers, visit the Hand-Held laser therapy page at the Bauman Medical website.
View the video from CBS/Dr. Sean reporting on the laser comb: